Daventry Group LP acquired a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 63,123 shares of the medical research company’s stock, valued at approximately $12,739,000. Charles […]
Daventry Group LP raised its position in New Relic, Inc. (NYSE:NEWR – Free Report) by 11.3% in the 1st quarter, Holdings Channel reports. The fund owned 285,646 shares of the software maker’s stock after acquiring an additional 28,919 shares during the period. New Relic accounts for approximately 15.0% of Daventry Group LP’s holdings, making the […]
Daventry Group LP increased its holdings in shares of Everbridge, Inc. (NASDAQ:EVBG – Free Report) by 23.8% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 558,678 shares of the technology company’s stock after buying an additional 107,530 shares during the quarter. […]
Health Catalyst, Inc. (NASDAQ:HCAT – Get Free Report) saw a large drop in short interest during the month of June. As of June 30th, there was short interest totalling 1,210,000 shares, a drop of 12.9% from the June 15th total of 1,390,000 shares. Based on an average daily volume of 451,000 shares, the days-to-cover ratio […]
Health Catalyst, Inc. (NASDAQ:HCAT – Get Rating) was the recipient of a significant drop in short interest in the month of May. As of May 31st, there was short interest totalling 1,520,000 shares, a drop of 14.6% from the May 15th total of 1,780,000 shares. Based on an average daily trading volume, of 460,900 shares, […]